JREM:XETRA JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc

EUR 27.34 0.47 1.730233
Icon

JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc (JREM:XETRA) Stock Analysis and Price Targets

ETF | Others | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 27.34

+0.47 (+1.73)%

EUR 1.12B

7.77K

EUR -1.00

N/A

Icon

JREM:XETRA

JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc (EUR)
ETF | XETRA
EUR 27.34
0.00 0
Take a Tour

JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc (JREM:XETRA) Stock Forecast

N/A

Based on the JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc stock forecast from 0 analysts, the average analyst target price for JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc is not available over the next 12 months. JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc’s stock price was EUR 27.34. JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc’s stock price has changed by +3.15% over the past week, +1.98% over the past month and +12.67% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...